2023-11-15T10:08:48-06:00 2022-12-31 411360831 OLSEN THIELEN & CO LTD 2675 LONG LAKE ROAD ST PAUL MN 55113 990 2022-01-01 850342069 NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY NORT 9526462047 1935 COUNTY ROAD B2 W 165 ROSEVILLE MN 55113 TOMA KINVILLE-OSSIAN EXECUTIVE DIRECTOR 9526462047 2023-11-09 1 TOMA KINVILLE-OSSIAN 999009999 1 RYAN VETTRUS CPA P01243596 6514834521 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z VALERIE BIOUSSE MD 1935 COUNTY ROAD B2 W 165 ROSEVILLE MN 55113 1483228 0 X WWW.NANOSWEB.ORG X 1986 NM EXCELLENCE IN PATIENT CARE THROUGH EDUCATION, RESEARCH & THE PRACTICE OF NEURO-OPHTHALMOLOGY. 14 12 0 200 0 0 61116 32937 918159 1381806 74550 50543 25186 17942 1079011 1483228 30000 5000 0 0 0 0 0 0 0 734350 1346799 764350 1351799 314661 131429 2976357 2666866 492200 419679 2484157 2247187 X DEDICATED TO ACHIEVING EXCELLENCE IN CARE OF PATIENTS WITH NEURO-OPHTHALMIC DISEASES BY THE SUPPORT AND PROMOTION OF EDUCATION, RESEARCH, AND THE PRACTICE OF NEURO-OPHTHALMOLOGY. 0 0 883973 5000 1244512 THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY (NANOS) IS THE ONLY ORGANIZATION DEDICATED TO THE ADVANCEMENT OF NEURO-OPHTHALMOLOGIC EDUCATION AND INFORMATION IN NORTH AMERICA. IN FEBRUARY 2022, NANOS SPONSORED ITS 48TH ANNUAL MEETING, OUR FIRST HYBRID MEETING AFTER THE PANDEMIC IN JW MARRIOT AUSTIN, AUSTIN TX. THE ON-DEMAND CONTENT OF OUR MEETING WAS AVAILABLE FOR 3 MONTHS AFTER OUR IN-PERSON MEETING. THE EDUCATIONAL MEETING INCLUDES SEMINARS, WORKSHOPS, HANDS-ON TRAINING, PLATFORM PRESENTATIONS, AND DISCUSSION OF CASES AND BEST PRACTICES IN NEURO-OPHTHALMIC RESEARCH, BASIC SCIENCE, AND PATIENT CARE. THE SOCIETY HAS ITS OWN JOURNAL, THE JOURNAL OF NEURO-OPHTHALMOLOGY, AND MAINTAINS A WEB PAGE THAT INCLUDES AN E-MAIL SCIENTIFIC DISCUSSION GROUP.NANOS USES MULTIPLE DATA SOURCES TO MEASURE THE IMPACT OF ITS EDUCATIONAL ACTIVITIES ON LEARNERS AND ON THE DISCIPLINE OF NEURO-OPHTHALMOLOGY. THESE MEASURES REFLECT PROFESSIONALS' NEED TO EXAMINE CURRENT PRACTICES, EVALUATE THE APPROPRIATENESS OF EDUCATIONAL ACTIVITIES IN ORDER TO IMPROVE THEIR LEVELS OF KNOWLEDGE OF NEURO-OPHTHALMOLOGY BASIC SCIENCE AND CLINICAL PRACTICE, COMPETENCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASE, AND PERFORMANCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASES.THE SOCIETY RECOGNIZES OUTSTANDING WORK AND PROVIDES BEST ABSTRACT AWARDS FOR PLATFORM AND POSTER PRESENTATIONS AT THE ANNUAL MEETING BY A RESIDENT, STUDENT OR FELLOW. THE SOCIETY GIVES A DISTINGUISHED SERVICE AWARD AT THE DISCRETION OF THE EXECUTIVE BOARD TO THOSE WHO HAVE PROVIDED A SUSTAINED AND SUBSTANTIAL SERVICE TO THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY.NANOS GIVES A YOUNG INVESTIGATOR AWARD. THIS AWARD WAS ESTABLISHED TO ENCOURAGE AND RECOGNIZE BASIC OR CLINICAL RESEARCH IN NEURO-OPHTHALMOLOGY BY A NANOS CANDIDATE OR ACTIVE MEMBER. THE ORIGINALITY, SCIENTIFIC MERIT AND NEURO-OPHTHALMIC INTEREST OF A DEVELOPING INVESTIGATOR'S TOTAL BODY OF WORK COMBINED WITH A REPRESENTATIVE NEW RESEARCH MANUSCRIPT WILL BE CONSIDERED AS CRITERIA TO DETERMINE THE AWARD RECIPIENT.NANOS RECOGNIZES THE NEED TO STIMULATE INVESTIGATOR-INITIATED RESEARCH PROGRAMS IN NEURO-OPHTHALMOLOGY. THE NANOS PILOT RESEARCH GRANT PROGRAM PROVIDES A ONE-YEAR, NON-RENEWABLE SOURCE OF FUNDING TO HELP PRINCIPAL INVESTIGATORS GENERATE PRELIMINARY DATA THAT WILL LEAD TO ADDITIONAL FUNDING FROM OTHER NATIONAL AGENCIES OR FOUNDATIONS.NANOS RECOGNIZES THE NEED TO STIMULATE LEADERSHIP DEVELOPMENT IN DIVERSE MEMBERS OF ITS COMMUNITY. THE DR. IVY DREIZIN LEADERSHIP DEVELOPMENT GRANT PROVIDES A ONE-TIME, NON-RENEWABLE SOURCE OF FUNDING TO SUPPORT LEADERSHIP DEVELOPMENT FOR A NANOS MEMBER. PRIORITY IS GIVEN TO THOSE WHO HAVE BEEN ACTIVELY INVOLVED IN THE WOMEN IN NEURO-OPHTHALMOLOGY COMMITTEE AND NANOS. NOMINEES AND ALTERNATES ARE SELECTED BY THE WOMEN IN NEURO-OPHTHALMOLOGY STEERING COMMITTEE, SUBJECT TO APPROVAL BY THE NANOS BOARD OF DIRECTORS. 883973 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 10 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 14 12 1 1 1 0 1 1 1 1 1 0 0 0 1 1 1 0 1 0 0 0 MN X GLOBAL MANAGEMENT PARTNERS LLC 9526462030 1935 COUNTY ROAD B2 W STE 165 ROSEVILLE MN 55113 X PREM SUBRAMANIAN MD PHD PRESIDENT 2.00 X X 0 0 0 PETER A QUIROS MD PRESIDENT ELECT 2.00 X X 0 0 0 MELISSA W KO MD VICE PRESIDENT 2.00 X X 0 0 0 HEATHER E MOSS MD PHD SECRETARY 2.00 X X 0 0 0 MARK MOSTER MD TREASURER 2.00 X X 0 0 0 ANDREW G LEE MD SENIOR VP NEURO-OPHTHALMIC ADVOCACY & PRACTICE 2.00 X X 0 0 0 NANCY J NEWMAN MD SENIOR VP NEURO-OPHTHALMIC EDUCATION 2.00 X X 0 0 0 LARRY FROHMAN MD EXECUTIVE VICE PRESIDENT 2.00 X X 0 0 0 VALERIE BIOUSSE MD IMMEDIATE PAST PRESIDENT/BOARD CHAIR 2.00 X 0 0 0 JOHN CHEN MD PHD BOARD MEMBER 2.00 X 0 0 0 JULIE FALARDEAU MD BOARD MEMBER 2.00 X 0 0 0 LYNN GORDON MD PHD BOARD MEMBER 2.00 X 0 0 0 KEVIN LAI MD BOARD MEMBER 2.00 X 0 0 0 VICTORIA PELAK MD BOARD MEMBER 2.00 X 0 0 0 LAURA BALCER MD EDITOR OF THE JOURNAL OF NEURO-OPHTHALMOLOGY 2.00 X 0 0 0 TOMA KINVILLE-OSSIAN CMP EXECUTIVE DIRECTOR 22.00 X 0 0 0 0 0 0 0 0 0 0 GLOBAL MANAGEMENT PARTNERS LLC 1935 COUNTY ROAD B2 W STE 165 ROSEVILLE MN 55113 MANAGEMENT SERVICES 398126 WOLTERS KLUWER 100 S 5TH STREET MINNEAPOLIS MN 55402 JNO SUBSCRIPTIONS 155236 2 32937 32937 ANNUAL SYMPOSIUMS 541900 860746 860746 MEMBERSHIP DUES 541900 282177 282177 JOURNAL OF NEURO-OPHTHALMOLOGY 513120 158501 3265 155236 EDITORIAL SUPPORT 513120 74509 74509 PUBLICATION 513120 5873 5873 1381806 50543 50543 MISCELLANEOUS 900099 17942 17942 17942 1483228 1244512 0 205779 5000 5000 398126 398126 385 385 8220 8220 45784 45784 8222 8222 2585 2585 604352 604352 4504 4504 JOURNAL 208896 208896 SPECIAL PROJECTS 53000 53000 LEADERSHIP 12625 12625 CME ADMINISTRATION 100 100 1351799 883973 467826 0 461608 326192 338357 451864 86176 57122 100190 63926 0 0 0 0 1990026 1767762 2976357 2666866 18647 21204 5000 0 468553 398475 492200 419679 X 2464783 2228729 19374 18458 2484157 2247187 2976357 2666866 131429 -368399 0 X X 0 1 X 1 0 X 34140 45775 35260 61116 32937 209228 999744 999811 1010580 918159 1381806 5310100 1033884 1045586 1045840 979275 1414743 5519328 0 0 0 5519328 55983 44634 54696 74550 50543 280406 55983 44634 54696 74550 50543 280406 9731 13893 15809 25186 17942 82561 1099598 1104113 1116345 1079011 1483228 5882295 0.93830 0.94000 0.04770 0.04800 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2018 AMOUNT: $ 9,731. 2019 AMOUNT: $ 13,893. 2020 AMOUNT: $ 15,809. 2021 AMOUNT: $ 25,186. 2022 AMOUNT: $ 17,942. 19374 916 18458 19000 1314 940 19374 20000 1000 19000 21000 1000 20000 22000 1000 21000 0.00000 0.00000 1.00000 0 0 0 X 1114829 -368399 -368399 1483228 0 1483228 1351799 0 1351799 0 1351799 PART X, LINE 2: THE SOCIETY IS CLASSIFIED AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND A SIMILAR SECTION OF THE MINNESOTA STATUTES. THEREFORE, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT INCLUDE A PROVISION FOR INCOME TAXES. THE SOCIETY REVIEWS INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN INCOME TAX RETURNS TO DETERMINE IF THERE ARE ANY INCOME TAX UNCERTAINTIES. THIS INCLUDES POSITIONS THAT THE ENTITY IS EXEMPT FROM INCOME TAXES OR NOT SUBJECT TO INCOME TAXES ON UNRELATED BUSINESS INCOME. THE SOCIETY RECOGNIZES TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE SOCIETY HAS IDENTIFIED NO SIGNIFICANT INCOME TAX UNCERTAINTIES. THE SOCIETY FILES INFORMATION RETURNS AS A TAX-EXEMPT ORGANIZATION. SHOULD THAT BE CHALLENGED IN THE FUTURE, ALL YEARS SINCE INCEPTION COULD BE SUBJECT TO REVIEW BY THE IRS. FORM 990, PART VI, SECTION A, LINE 2 DRS. VALARIE BIOUSSE AND NANCY NEWMAN ARE PARTNERS AND SERVE ON THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 3 THE SOCIETY HAS CONTRACTED WITH GLOBAL MANAGEMENT PARTNERS, LLC TO PROVIDE OFFICE SPACE AND ADMINISTRATIVE SERVICES TO THE ORGANIZATION. TAMARA KINVILLE-OSSIAN, THE ORGANIZATION'S EXECUTIVE DIRECTOR, IS EMPLOYED BY GLOBAL MANAGEMENT PARTNERS, LLC. DURING THE TAX YEAR ENDED DECEMBER 31, 2022, THE SOCIETY PAID $398,126 TO GLOBAL MANAGEMENT PARTNERS, LLC FOR OFFICE SPACE AND ADMINISTRATION FEES. FORM 990, PART VI, SECTION A, LINE 4 THE PROPOSED AMENDMENT ABOUT A NEW INTERNATIONAL BOARD MEMBER HAS BEEN APPROVED BY THE NANOS MEMBERSHIP. THE SUMMARY OF THE BYLAWS CHANGES: INTERNATIONAL BOARD MEMBER IS TO BE APPOINTED AT THE DISCRETION OF PRESIDENT FOR A 2-YEAR TERM WITH ALLOWANCE FOR REAPPOINTMENT TWICE (TOTAL OF 6 YEARS). - THE TERM WILL COINCIDE WITH THE OFFICER ROTATION CYCLE. - THIS POSITION IS NON-VOTING, ADVISORY. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS TEN MEMBERSHIP CLASSES, AS DEFINED IN THE ORGANIZATION'S BYLAWS, ARTICLE II. FORM 990, PART VI, SECTION A, LINE 7A FIVE CLASSES OF MEMBERSHIP, AS DETAILED IN THE ORGANIZATION'S BYLAWS, HAVE VOTING RIGHTS AND ELECT THE OFFICERS AND OTHER MEMBERS OF THE EXECUTIVE BOARD. FORM 990, PART VI, SECTION A, LINE 7B ELIGIBLE VOTING MEMBERS MAY AMEND, ALTER, OR REPEAL THE BYLAWS OF THE ORGANIZATION WITH A TWO-THIRDS MAJORITY. FORM 990, PART VI, SECTION B, LINE 11B THE AUDITED FINANCIAL STATEMENTS, UPON WHICH THIS FORM 990 IS BASED, WERE REVIEWED BY THE ORGANIZATION'S TREASURER. THE FORM 990 WILL BE REVIEWED BY THE ORGANIZATION'S ACCOUNTING TEAM, EXECUTIVE DIRECTOR, AND TREASURER BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C PURSUANT TO THE ORGANIZATION'S WRITTEN CONFLICT OF INTEREST DISCLOSURE POLICY, THE NANOS EXECUTIVE COMMITTEE WILL OBTAIN AND CONFIDENTIALLY REVIEW INFORMATION FROM LEADERSHIP AND STAFF ON AN ANNUAL DISCLOSURE REVIEW FORM, AND ALERT THE BOARD OF ANY SERIOUS CONFLICTS. COMPLETION OF THE CONFLICT OF INTEREST DISCLOSURE FORM WILL SATISFY THE DISCLOSURE REQUIREMENTS OF THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION DOES NOT HAVE ANY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 INSPECTION IS AVAILABLE BY APPOINTMENT WITH THE GMP PARTNER. FORM 990, PART XII LINE 2C THE ORGANIZATION'S FINANCE COMMITTEE HAS RESPONSIBILITY FOR OVERSIGHT OF THE FINANCIAL REVIEW, SELECTION OF THE INDEPENDENT AUDITOR AND RELATED MATTERS. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.